Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Flow Chemistry Congress 2018

Flow Chemistry Congress 2018 Agenda

Research Towards Automated Continuous Flow Peptide Synthesis

Duncan Guthrie, Director & Owner, Vapourtec, Ltd.

Today, the focus of therapeutic pharmaceuticals is beginning to shift away from small molecular medicines and towards larger, peptide based treatments. Peptides have enormous potential as medicinal compounds. They are highly specific and often potent. Solid phase approaches to peptide synthesis are attractive, however challenges remain.  This presentation describes the key achievements in Vapourtec’s work towards gaining benefit from continuous flow approaches to solid phase peptide synthesis.